Phase II Randomized Trial of Gemcitabine and Cisplatin with or without Cetuximab in Patients with Urothelial Carcinoma May 5, 2022 By Jesse Bufkin
A fixed-sequence pilot study of the role of CYP2B6, CYP2Y4 and MDR1 in the Metabolic Clearance of Methadone May 5, 2022 By Jesse Bufkin
Positron Emission Tomography Imaging of Bone in Batients with Metastatic Prostate Cancer – A Pilot Study Evaluating Treatment Response May 5, 2022 By Jesse Bufkin
A Phase I Study Combining Escalating Doses of Radiolabeled BC8 (Anti-CD45) Antibody with Fludarabine, Low Dose TBI, PBSC Infusion and Post-Transplant Immunosuppression with Cyclosporine and Mycophenolate Mofetil to Establish Mixed or Full Donor Chimerism May 5, 2022 By Jesse Bufkin
A Phase III Trial Of Short Term Androgen Deprivation With Pelvic Lymph Node Or Prostate Bed Only Radiotherapy (SPPORT) In Prostate Cancer Patients With A Rising PSA After Radical Prostatectomy May 5, 2022 By Jesse Bufkin
Prospective, Randomized, Controlled, Multicenter Trial of the Memokath® 044TW Thermo-Expandable Stent for Maintaining Urethral Patency in Patients After Dilation or Internal Urethrotomy of Recurrent Stricture of the Bulbar Urethra May 5, 2022 By Jesse Bufkin
A 5-year Registry study of Humira (Adalimumab ) in subjects with moderately to severly active Crohn’s Disease (CD) May 5, 2022 By Jesse Bufkin
Stenting and Angioplasty with Protection in Patients with High-Risk for Endartectomy May 5, 2022 By Jesse Bufkin
